Regulatory headwinds have Echelon Capital Markets analyst Andrew Semple downgrading Indiva.

Related Keywords

Canada , Canadian , Andrew Semple , Health Canada , Competition Bureau , Echelon Capital Markets , Indiva Stock Quote ,